With only 70 months left to meet the SDGs, the world faces a stark reality in the fight against AIDS, requiring urgent action ...

Jarunee Siriphan, director at the Foundation for Action on Inclusion Rights (Fair) and founder of the People's Movement to ...

The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

The cancellation of USAID contracts has threatened critical global health research. Plus, new guidance to prevent HIV in ...

The PETITE-DTG study evaluated dolutegravir (DTG) — a drug that revolutionized HIV treatment in adults and children — in ...

The rollback of funding for anti-malaria efforts in the Mekong is just one of many examples of cuts that are raising alarm ...

Nearly half (44%) of all new HIV infections globally in 2023 were in women and girls.1 Adolescent girls and young women are disproportionately affected by HIV, particularly in sub-Saharan Africa where ...

The "Thailand Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2025 Update" report has been added to ResearchAndMarkets.com's offering. The gift card market ...

By Gift BritonFor the first time, infants younger than 28 days (neonates) can safely receive Dolutegravir (DTG), one of the most effective and widely used HIV drugs worldwide.Since the World Health ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...